Clinical Trials in Illinois

Showing 3521-3540 of 9,411 trials

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

NCT03734588

SPK-8016 is in development for the treatment of patients with inhibitors to FVIII. This Phase 1/2, open-label, non-randomized, dose-finding study to evaluate the safety, efficacy, and tolerability of SPK-8016 in adult males with severe hemophilia A and no measurable inhibitor against FVIII.

Adeno-Associated Virus (AAV)Blood Coagulation DisorderBlood Coagulation Disorders, Inherited+14 more

Spark Therapeutics, Inc.4 participantsStarted Jan 2019

Los Angeles, California, United States • Peoria, Illinois, United States • Ann Arbor, Michigan, United States +8 more locations

COMPLETEDNA44 miles

Calm Athlete: Feasibility of App-based Mindfulness Training on Collegiate Student-Athletes' Mental Wellbeing

NCT06050681

The goal of this clinical trial is to evaluate the feasibility of a mobile app-based mindfulness training program in collegiate student-athletes. The main questions it aims to answer are: * Is a app-based mindfulness program feasible for use with collegiate student athletes? * What, if any, benefits are seen in the mental wellbeing of collegiate student athletes following mindfulness training? Participants will use the Calm app to complete semi-structured program of 21 mindfulness sessions over 6 weeks. Participants will complete each 8-15 minute sessions at a location and time of their choosing.

MindfulnessMental Health Wellness

University of Illinois at Urbana-Champaign30 participantsStarted Aug 2023

Urbana, Illinois, United States

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

Calm Athlete: Feasibility of App-based Mindfulness Training on Collegiate Student-Athletes' Mental Wellbeing

Find Trials by Condition in Illinois

Reducing Opioid Mortality in Illinois

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia

Development and Testing of a Pediatric Cervical Spine Injury Risk Assessment Tool

A Study of LY3471851 in Participants With Psoriasis

DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)

Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)

Phase 3 Study of SNF472 for Calciphylaxis

ELUCIDATE FFRct Study

A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes

Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia

COMbination of Bipolar Androgen Therapy and Nivolumab

A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients

A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes